Rights and permissions
About this article
Cite this article
Lumiracoxib hits the tolerability TARGET in osteoarthritis. React. Wkly. 1054, 4 (2005). https://doi.org/10.2165/00128415-200510540-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200510540-00012